The team

Arctic Aurora LifeScience is managed by a highly experienced and complementary team with a broad successful track record in equity asset management, pharmaceutical product development and commercialization, financing, M&A and risk management.

The team has deep knowledge and coverage of both the US and Europe Life Science market with a unique network within pharma, biotech, life science and the investment community. Their long standing relationship with management teams and industry thought leaders provides unparalleled awareness of opportunities. 




Ulrica Slåne Bjerke

CIO Arctic Aurora LifeScience

Mobile:+46 720 507885
Office:+46 8 44686107

Ulrica has the overall responsibility for Arctic Aurora LifeScience investment portfolio.
She has ca 30 years of successful track record as a Portfolio Manager in Health
Care and has been a top ranked Health care Analyst for (10 years). Ulrica has an MBASc,
CEFA, with a degree from Stockholm School of Economics and Medicine at the
Karolinska Institute.



Torbjørn Bjerke

Portfolio Manager Arctic Aurora LifeScience

Mobile: +46 72 050 7884
Office:+46 8 44686108

Mr. Torbjørn Bjerke is a Medical Doctor with the responsibility of scientific, clinical and
regulatory due dilligence of new opportunities and portfolio management in Arctic Aurora
LifeScience. He has ca 30 years of executive experience within successful drug
development and business development/M&A in both public and private science companies.

Mr. Bjerke got his doctor degree from the University of Aarhus.



Daniel Bolanowski

Analyst Arctic Aurora LifeScience

Mobile:+46 72 050 7886
Office:+46 8 44686109

Daniel fills the role as an analyst in Arctic Aurora LifeScience with the responsibility of
reaserch, value tracking. valuation, opportunity sourcing. He has more than 5 years
experience as business analyst and has had several engagements for small
biotech/medtech companies.

Daniel has a MSc (Biotech) and a MSc (Business/Economics) from the University of Uppsala.


Sales and Product Specialist

For general enquiries and information on how to invest in Arctic Aurora Life Science, please send an e-mail to or contact Sales and Product Specialist:

Vegard Gjølme - Norway / Int'l
Phone:       +4721013253
Mobile:       +4748403253

Anna Jakobsen - Sweden
Spring Green Capital
Phone:       + 46 8 72 050 90 24



Visting address Stocholm

Visiting address Stockholm is Regeringsgatan 38, Stockholm

Advisory Board

A group consisting of highly senior executives from the pharmaceutical, biotechnology and banking sector acts as a sounding board to the portfolio management team on specific topics regarding scientific advice during due diligence and identification of investment ideas on particular therapeutic areas and upcoming technologies, strategic advice and deal access.     



Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish AP3 Fonder, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both hedged and un-hedged share classes.

Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.